MEASUREMENT OF CAUDATE-NUCLEUS AREA - A MORE ACCURATE MEASUREMENT FOR HUNTINGTONS-DISEASE

被引:9
作者
WARDLAW, JM
SELLAR, RJ
ABERNETHY, LJ
机构
[1] WESTERN GEN HOSP,DEPT NEURORADIOL,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND
[2] ROYAL INFIRM,DEPT RADIOL,EDINBURGH EH3 9HB,MIDLOTHIAN,SCOTLAND
关键词
HUNTINGTONS DISEASE; CAUDATE NUCLEUS; CHOREA;
D O I
10.1007/BF00587814
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Caudate nucleus atrophy occurs in Huntington's disease and methods of measuring this have been described using axial CT, but these are indirect and lack sensitivity We measured caudate nucleus area (blind to the subjects' clinical state) in 30 subjects with or at risk of Huntington's disease, and in 100 normal age matched controls. Fifteen subjects with established symptomatic Huntington's disease, 3 with early symptoms, and 3 presymptomatic subjects (2 showing a high probability for the Huntington's disease gene on genetic testing, and one who has since developed symptoms) were correctly identified. Three normal (gene negative) family members were also correctly identified. Outcome is awaited in 6. CT caudate area measurement is simple and reproducible and we have found it to be a useful confirmatory test for Huntington's disease.
引用
收藏
页码:316 / 319
页数:4
相关论文
共 19 条
[1]   BICAUDATE INDEX IN COMPUTERIZED TOMOGRAPHY OF HUNTINGTON DISEASE AND CEREBRAL ATROPHY [J].
BARR, AN ;
HEINZE, WJ ;
DOBBEN, GD ;
VALVASSORI, GE ;
SUGAR, O .
NEUROLOGY, 1978, 28 (11) :1196-1200
[2]   POSITRON EMISSION TOMOGRAPHIC SCAN INVESTIGATIONS OF HUNTINGTONS-DISEASE - CEREBRAL METABOLIC CORRELATES OF COGNITIVE FUNCTION [J].
BERENT, S ;
GIORDANI, B ;
LEHTINEN, S ;
MARKEL, D ;
PENNEY, JB ;
BUCHTEL, HA ;
STAROSTARUBINSTEIN, S ;
HICHWA, R ;
YOUNG, AB .
ANNALS OF NEUROLOGY, 1988, 23 (06) :541-546
[3]   MORPHOMETRIC DEMONSTRATION OF ATROPHIC CHANGES IN THE CEREBRAL-CORTEX, WHITE MATTER, AND NEOSTRIATUM IN HUNTINGTONS-DISEASE [J].
DELAMONTE, SM ;
VONSATTEL, JP ;
RICHARDSON, EP .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1988, 47 (05) :516-525
[4]  
FOLSTEIN SE, 1983, NEUROBEH TOXICOL TER, V5, P605
[5]   PREDICTIVE TESTING FOR HUNTINGTONS-DISEASE [J].
HARPER, PS ;
MORRIS, MJ .
BRITISH MEDICAL JOURNAL, 1989, 298 (6671) :404-405
[6]   THE COMBINED USE OF POSITRON EMISSION TOMOGRAPHY AND DNA POLYMORPHISMS FOR PRECLINICAL DETECTION OF HUNTINGTONS-DISEASE [J].
HAYDEN, MR ;
HEWITT, J ;
STOESSL, AJ ;
CLARK, C ;
AMMANN, W ;
MARTIN, WRW .
NEUROLOGY, 1987, 37 (09) :1441-1447
[7]  
Hayden MR., 1981, HUNTINGTONS CHOREA, P45
[8]   LATE ONSET OF HUNTINGTONS-DISEASE [J].
MYERS, RH ;
SAX, DS ;
SCHOENFELD, M ;
BIRD, ED ;
WOLF, PA ;
VONSATTEL, JP ;
WHITE, RF ;
MARTIN, JB .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (06) :530-534
[9]   DECREASED I-123 IMP CAUDATE-NUCLEUS UPTAKE IN PATIENTS WITH HUNTINGTONS-DISEASE [J].
NAGEL, JS ;
JOHNSON, KA ;
ICHISE, M ;
ENGLISH, RJ ;
WALSHE, TM ;
MORRIS, JH ;
HOLMAN, BL .
CLINICAL NUCLEAR MEDICINE, 1988, 13 (07) :486-490
[10]  
NEOPHYTIDES AN, 1979, ADV NEUROL, V23, P185